Delayed contrast-enhanced MRI: Use in myocardial viability assessment and other cardiac pathology

European Radiology, Supplement

Volumn 15, Issue ISSUENR. 2, 2005, Pages

  Bogaert, Jan ^a   Dymarkowski, Steven ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Contrast agent; Heart, imaging; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

CONGESTIVE CARDIOMYOPATHY; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; IMAGE ANALYSIS; INTRACARDIAC THROMBOSIS; ISCHEMIC HEART DISEASE; MITRAL VALVE STENOSIS; MYOCARDIAL DISEASE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; PERICARDITIS; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; TISSUE SURVIVAL;

EID: 15844394439     PISSN: 16133749     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10406-005-0093-x     Document Type: Review

References (28)

1. Bogaert J, Dymarkowski S, Taylor AM (2005) Clinical cardiac MRI. Springer, Berlin Heidelberg New York
2. Bogaert J, Taylor AM, Van Kerckhove F, Dymarkowski S (2004) Use of inversion recovery contrast-enhanced MRI for cardiac imaging: Spectrum of applications. Am J Roentgenol 182:609-615
3. Goldman MR, Brady TJ, Pykett IL, et al (1982) Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation 66:1012-1016
4. De Roos A, Van Rossum AC, Van der Wall E, et al (1989) Reperfused and nonreperfused myocardial infarction: Diagnostic potential of Gd-DTPA enhanced MR imaging. Radiology 172:717-720
5. Simonetti OP, Kim RJ, Fieno DS, et al (2001) An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218:215-223
6. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985-1991
7. Wagner A, Mahrholdt H, Holly TA, et al (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 361:374-379
8. Kim JR, Wu E, Rafael A, et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445-1453
9. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM (2000) Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 102:1678-1683
10. Gerber BL, Rochitte CE, Bluemke DA, et al (2001) Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation 104:998-1004
11. Wu E, Judd RM, Vargas JD, et al (2001) Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 357:21-28
12. Gerber BL, Rochitte CE, Melin JA, et al (2000) Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation 101:2734-2741
13. Wellnhofer E, Olariu A, Klein C, et al (2004) Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation 109:2172-2174
14. Kim RJ, Manning WJ (2004) Viability assessment by delayed enhancement cardiovascular magnetic resonance: Will low-dose dobutamine dull the shine? Circulation 109:2476-2479
15. Sensky PR, Jivan A, Hudson NM, et al (2000) Coronary artery disease: combined stress MR imaging protocol - one-stop evaluation of myocardial perfusion and function. Radiology 215:608-614
16. Plein S, Ridgway JP, Jones TR, et al (2002) Coronary artery disease: assessment with a comprehensive MR imaging protocol - initial results. Radiology 225:300-307
17. Chiu CW, So NM, Lam WWM, et al (2003) Combined first-pass perfusion and viability study at MR imaging in patients with non-segment ST-segment-elevation acute coronary syndromes: Feasibility study. Radiology 226:717-722
18. Kwong RY, Schussheim AE, Rekhraj S, et al (2003) Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 107:531-537
19. Schulz-Menger J, Gross M, Messroghli D, et al (2003) Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol 42:513-518
20. Mahrholdt H, Goedecke C, Wagner A, et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis. A comparison to histology and molecular pathology. Circulation 109:1250-1258
21. McCrohon JA, Moon JCC, Prasad SK, et al (2003) Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 108:54-59
22. Choudhury L, Mahrholdt H, Wagner A, et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40:2156-2164
23. Moon JCC, McKenna WJ, McCrohon JA, et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41:1561-1567
24. Bogaert J, Goldstein M, Tannouri F, Golzarian J, Dymarkowski S (2003) Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MRI imaging. AJR 180:981-985
25. Moon JC, Mundy HR, Lee PJ, Mohiaddin RH, Pennell DJ (2003) Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation 107:e47
26. Tandri H, Martinez C, Saranathan M, et al (2004) Non-invasive detection of myocardial fibrosis in arrhythmogenic right ventricular dysplasia by delayed-enhancement magnetic resonance imaging - correlation with histopathology (abstract). J Cardiovasc Magn Reson 6:44-45
27. Van Dockum WG, ten Gate FJ, ten Berg JM, et al (2004) Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic cardiomyopathy: Evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43:27-34
28. Mollet NR, Dymarkowski S. Volders W, et al (2002) Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 106:2873-2876